SMAD6 and epilepsy: Pathogenic variants in genes, such as PGAP3, CHD3, and SMAD6, can impair motor and cognitive performance without producing major neurological symptoms like epilepsy, suggesting that these deficits arise from developmental or structural abnormalities rather than from direct neurodegeneration.